Celcuity (CELC) Current Assets (2016 - 2026)
Celcuity's (CELC) quarterly Current Assets came in at $465.7 million in Q4 2025, up 90.4% YoY from $244.6 million in Q4 2024, and down 2.07% on a QoQ basis from $475.5 million in Q3 2025.
Celcuity (CELC) Current Assets (2016 - 2026) Analysis & Trends
Celcuity (CELC) has 10 years of Current Assets data on file, last reported at $465.7 million in Q4 2025.
- Quarterly Current Assets rose 90.4% year-over-year to $465.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $465.7 million (up 90.4% YoY) and the FY2025 annual result came in at $465.7 million, up 90.4% from the prior year.
- Current Assets slipped to $465.7 million in Q4 2025, from $475.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $475.5 million in Q3 2025 to a low of $35.7 million in Q1 2021.
- A 5-year average of $181.7 million and a median of $169.6 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets jumped 601.51% — and 2025, when it plunged 37.28%.
- Tracing CELC's Current Assets over 5 years: stood at $85.4 million in 2021, then soared by 105.26% to $175.2 million in 2022, then grew by 8.79% to $190.6 million in 2023, then grew by 28.32% to $244.6 million in 2024, then surged by 90.4% to $465.7 million in 2025.
- The last three Current Assets figures came in at $465.7 million (Q4 2025), $475.5 million (Q3 2025), and $183.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 775.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 775.84 Mn |
| Dec 31, 2025 | 465.66 Mn |
| Sep 30, 2025 | 475.50 Mn |
| Jun 30, 2025 | 183.10 Mn |
| Mar 31, 2025 | 217.60 Mn |
| Dec 31, 2024 | 244.57 Mn |
| Sep 30, 2024 | 272.44 Mn |
| Jun 30, 2024 | 291.93 Mn |
| Mar 31, 2024 | 187.52 Mn |
| Dec 31, 2023 | 190.59 Mn |
| Sep 30, 2023 | 141.71 Mn |
| Jun 30, 2023 | 152.81 Mn |
| Mar 31, 2023 | 164.10 Mn |
| Dec 31, 2022 | 175.19 Mn |
| Sep 30, 2022 | 64.69 Mn |
| Jun 30, 2022 | 71.96 Mn |
| Mar 31, 2022 | 79.44 Mn |
| Dec 31, 2021 | 85.35 Mn |
| Sep 30, 2021 | 91.18 Mn |
| Jun 30, 2021 | 42.25 Mn |